MiQLab® System Testimonial – Denver Animal Emergency

by | Jun 7, 2021 | Veterinary Diagnostics

Home » Veterinary Diagnostics » MiQLab® System Testimonial – Denver Animal Emergency
Denver Animal Emergency

About Denver Animal Emergency

Dr. Andrew Pierce, Owner and Medical Director of Denver Animal Emergency in North Carolina, shares his experiences with MiQLab in this testimonial video.

As a LexaGene customer, Denver Animal Emergency is using MiQLab System inside the clinic to enable evidence based treatment practices, to reduce reliance on sending samples out for testing, and to gain insight into antimicrobial resistance factors.

<a href="https://lexagene.com/author/lexagene-admin/" target="_self">LexaGene</a>

LexaGene

LexaGene is a molecular diagnostics company that has commercialized the MiQLab System for fast and easy detection of biological contaminants, pathogens and other molecular markers.

The Value of a Filter-Based Sample Preparation Cartridge Used in a PCR Device for Sensitive and Rapid Detection of Contaminants

LexaGene’s MiQLab™ System is the only fully automated system on the market today that is equipped with a disposable filter-based sample preparation cartridge that allows for efficient processing of large volumes of sample for sensitive detection of contaminants.

Survey Says Veterinarians Have an Appetite for In-Clinic Diagnostic Technology

This spring LexaGene conducted a market research survey in conjunction with AAHA to assess the opinions of practicing veterinarians on AMR stewardship and the use of antibiotics in the treatment of companion animals.

The Dawn of the Superbugs

The most menacing of all resistant bacteria are the so called “super bugs”- strains of bacteria that are resistant to several different classes of antibiotics or multidrug resistant.

Upcoming Events

LexaGene will be exhibiting AAHA's Connexity Event in September.
1 2 3 8

Latest Resources


In this webinar, Dr. Jane Sykes details data from a multi-center study using the MiQLab® System for diagnosing urinary tract infections.
1 2 3 28